RTW · LONDON STOCK EXCHANGE ·
RTW Venture Fund Ltd
Monthly Valuation Update and Factsheet
Our AI’s take
RTW Biotech Opportunities reported a monthly decline in unaudited NAV per ordinary share, alongside positive annualised NAV performance since launch.
The full digestion is for members. What is good, what is bad and why, the numbers that matter, and the chart, then ask about it by voice or text.
Join freeNew to announcements? Learn what an RNS is and why prices move.